Pacira Biosciences Inc
NASDAQ:PCRX
Wall Street
Price Targets
PCRX Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
PCRX
is 46.24 USD
with a low forecast of 36.36 USD and a high forecast of 59.85 USD.
PCRX Last Price Targets
Pacira Biosciences Inc
The latest public price target was made on Sep 10, 2023 by
Pacira BioSciences
from
H.C. Wainwright
,
who expects
PCRX
stock to
rise by 133%
over the next 12 months.
You can read more about this price target by viewing
the article on Defense World.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Pacira BioSciences
H.C. Wainwright
|
63
USD
Upside 133% |
7 months ago
Sep 10, 2023
|
Pacira BioSciences (NASDAQ:PCRX) Hits New 52-Week Low at $34.00
Defense World
|
|
Pacira BioSciences
New Street
|
68
USD
Upside 152% |
7 months ago
Sep 10, 2023
|
Pacira BioSciences (NASDAQ:PCRX) Hits New 52-Week Low at $34.00
Defense World
|
Pacira BioSciences
Truist Financial
|
55
USD
Upside 104% |
7 months ago
Sep 10, 2023
|
Pacira BioSciences (NASDAQ:PCRX) Hits New 52-Week Low at $34.00
Defense World
|
Pacira BioSciences
Needham
|
52
USD
Upside 93% |
7 months ago
Sep 10, 2023
|
Pacira BioSciences (NASDAQ:PCRX) Hits New 52-Week Low at $34.00
Defense World
|
Operating Income
Forecast
Operating Income Estimate
Pacira Biosciences Inc
For the last 8 years the
compound annual growth rate for
Pacira Biosciences Inc's operating income is
32%.
The projected
CAGR
for the next 3 years is
50%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PCRX's stock price target?
Price Target
46.24
USD
According to Wall Street analysts, the average 1-year price target for
PCRX
is 46.24 USD
with a low forecast of 36.36 USD and a high forecast of 59.85 USD.
What is Pacira Biosciences Inc's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Pacira Biosciences Inc's revenue is
13%.
The projected
CAGR
for the next 3 years is
8%.
What is Pacira Biosciences Inc's Operating Income forecast?
Projected CAGR
50%
For the last 8 years the
compound annual growth rate for
Pacira Biosciences Inc's operating income is
32%.
The projected
CAGR
for the next 3 years is
50%.
What is Pacira Biosciences Inc's Net Income forecast?
Projected CAGR
69%
For the last 8 years the
compound annual growth rate for
Pacira Biosciences Inc's net income is
47%.
The projected
CAGR
for the next 3 years is
69%.
You don't have any saved screeners yet
